Mankind Pharma Ltd share price logo

Mankind Pharma Share Price

NSE: MANKIND

BSE: 543904

Mid Cap

Healthcare Sector

₹2060.50

-18.50

(-0.89%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Mankind Pharma Stock Performance

as on February 13, 2026 at 9:31 pm IST

  • Day's Low

    Day's High

    ₹2,050.10
    ₹2,085.30
    downward going graph

    0.50%

    Downside

    1.20%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹2,033.00
    ₹2,716.50
    downward going graph

    1.33%

    Downside

    31.84%

    Upside

    downward going graph

Mankind Pharma share price movements today

Previous Close
₹2,079.00
Open
₹2,076.10
Volume
2.08L
Upper Circuit
₹2,286.90
Lower Circuit
₹1,871.10
Day's Low - High
₹2,050.10 - ₹2,085.30
52 Week Low - High
₹2,033.00 - ₹2,716.50

Mankind Pharma Historical Returns

1 Month Return
-5.28 %
3 Month Return
-8.3 %
1 Year Return
-12.17 %
3 Year Return
+ 44.87 %
5 Year Return
+ 44.87 %

Mankind Pharma Fundamentals

as on February 13, 2026 at 4:01 pm IST

Market Cap

₹85,058.49 Cr

Return on Equity (ROE)

13.89

PE Ratio (TTM)

47.81

Return on capital employed (ROCE)

14.88

Industry PE ratio

41.52

Beta (LTM)

0.67

P/B Ratio

6.83

Dividend Yield

0

PEG Ratio

-6.11

Quarterly Earnings Growth YOY

7.64

EPS (TTM)

48.74

Sector

Pharmaceuticals

Book Value

347.37

Technical Analysis

Bearish

View Technical Analysis

Mankind Pharma Stock Valuation

as on February 13, 2026 at 4:01 pm IST

Mankind Pharma in the last 5 years

  • Overview

  • Trends

Lowest (40.63x)

August 5, 2024

Industry (41.52x)

February 13, 2026

Today (47.81x)

February 13, 2026

Highest (58.15x)

October 7, 2025

LowHigh

Today’s Price to Earnings Ratio: 47.81x

Mankind Pharma Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Mankind Pharma with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Mankind Pharma Ltd image
Mankind Pharma Ltd
BUY85,058.498.97%0.692,01112,207
Glenmark Pharmaceuticals Ltd image
Glenmark Pharmaceuticals Ltd
BUY56,372.4361.43%0.621,04713,321
Ajanta Pharma Ltd image
Ajanta Pharma Ltd
BUY36,482.4528.46%0.529204,648
Ipca Laboratories Ltd image
Ipca Laboratories Ltd
BUY37,685.2211.33%0.657878,939
Alkem Laboratories Ltd image
Alkem Laboratories Ltd
HOLD64,594.9917.44%0.592,21612,964
See all

Analyst Recommendation on Mankind Pharma Stock

Based on 17 analysts

BUY

64.71%

Buy

17.65%

Hold

17.65%

Sell

Based on 17 analysts, 64.71% of analysts recommend a 'BUY' rating for Mankind Pharma. Average target price of ₹2500

Source: S&P Global Market Intelligence

Mankind Pharma Share Price Target

Get share price movements and forecasts by analysts on Mankind Pharma.

What analysts predicted

21.33%UPSIDE

Target Price

₹2500

Current Price

₹2060.5

Analyzed by

17 Analysts

High

₹3100

Target

₹2500.00

Low

₹1990

Mankind Pharma target price ₹2500, a slight upside of 21.33% compared to current price of ₹2060.5. According to 17 analysts rating.

Source: S&P Global Market Intelligence

Mankind Pharma Stock’s Investor Sentiment and Interest

Investment in Mankind Pharma Ltd Shares on INDmoney has grown by 49.52% over the past 30 days, indicating increased transactional activity.

Time period: to

Change:49.52% versus previous 30 day period

Search interest for Mankind Pharma Ltd Stock has increased by 14% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:14% versus previous 30 day period

Mankind Pharma Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Sales
2,052.67
2,578.62
2,708.1
2,606.95
2,422.24
2,867.85
3,061.43
3,198.79
3,079.37
3,570.35
3,697.16
3,567.2
Other Income
50.28
63.35
63.45
74.73
94.56
107.9
111.63
87.09
253.65
83.05
94.19
75.96
Total Income
2,102.95
2,641.97
2,771.55
2,681.68
2,516.8
2,975.75
3,173.06
3,285.88
3,333.02
3,653.4
3,791.35
3,643.16
Expenses
1,635.99
1,923.81
2,025.45
2,000.45
1,836.27
2,196.29
2,216.61
2,382.8
2,400.52
2,723.58
2,775.83
2,754.36
Operating Profit
416.68
654.81
682.65
606.5
585.97
671.56
844.82
815.99
678.85
846.77
921.33
812.84
Operating Profit Margin %
20.3%
25.39%
25.21%
23.26%
24.19%
23.42%
27.6%
25.51%
22.05%
23.72%
24.92%
22.79%
Profit Before Interest, Tax and Depreciation
466.96
718.16
746.1
681.23
680.53
779.46
956.45
903.08
932.5
929.82
1,015.52
888.8
Interest
5.16
6.34
8.62
9.19
9.17
10.84
7.1
220.93
190.54
170.65
169.68
157.2
Depreciation
84.52
87.35
96.49
109.72
99.78
102.69
100.49
187.17
230.87
218.68
221.82
222.6
Profit Before Tax
377.28
624.47
640.99
562.32
571.58
665.93
848.86
494.98
511.09
540.49
624.02
509
Tax Paid
83.59
130.28
129.81
102.51
94.99
122.86
189.98
110.46
86.44
95.87
103.84
95.12
Profit After Tax
293.7
494.19
511.18
459.81
476.59
543.07
658.88
384.52
424.65
444.62
520.18
413.88
Total Net profit including share of profit / Loss from associate company
293.7
494.19
511.18
459.81
476.59
543.07
658.88
384.52
424.65
444.62
520.18
413.88
EPS
7.13
12.15
12.51
11.33
11.76
13.39
16.31
9.46
10.19
10.62
12.39
9.9
Actual EPS
7.13
12.15
12.51
11.33
11.76
13.39
16.31
9.46
10.19
10.62
12.39
9.9
Adjusted EPS
7.13
12.15
12.51
11.33
11.76
13.39
16.31
9.46
10.19
10.62
12.39
9.9
Diluted EPS
7.13
12.14
12.49
11.31
11.74
13.37
16.28
9.44
10.18
10.6
12.38
9.89

Mankind Pharma Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Sales
5,865.23
6,214.43
7,781.56
8,749.43
10,260.44
12,207.44
Other Income
121.96
182.63
210.48
140.99
296.41
553.56
Total Income
5,987.19
6,397.06
7,992.03
8,890.42
10,556.85
12,761
Expenses
4,428.42
4,566.33
5,792.2
6,848.8
7,746.76
9,189.51
Operating Profit
1,436.81
1,648.1
1,989.36
1,900.63
2,513.68
3,017.93
Operating Profit Margin %
24.5%
26.52%
25.57%
21.72%
24.5%
24.72%
Profit Before Interest, Tax and Depreciation
1,558.77
1,830.73
2,199.83
2,041.63
2,810.09
3,571.49
Interest
21.97
20.15
58.61
44.47
32.75
429.41
Depreciation
99.06
118.97
166.62
325.92
378.42
621.22
Profit Before Tax
1,437.74
1,691.61
1,974.6
1,671.24
2,398.92
2,520.86
Tax Paid
381.59
398.58
521.64
361.57
457.15
509.74
Profit After Tax
1,056.15
1,293.03
1,452.96
1,309.68
1,941.77
2,011.12
Total Net profit including share of profit / Loss from associate company
1,056.15
1,293.03
1,452.96
1,309.68
1,941.77
2,011.12
EPS
26.36
32.28
35.78
32
47.75
49.28
Actual EPS
26.36
32.28
35.78
32
47.75
49.28
Adjusted EPS
26.36
32.28
35.78
32
47.75
49.28
Diluted EPS
26.36
32.28
35.78
32
47.68
49.19

Mankind Pharma Ltd Cash Flow

Figures in Rupees Crores

Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
1,069.71
1,137.24
919.78
1,813.3
2,152.44
2,413.38
Cash Flow from Investing Activities
-435.54
-1,221.85
-1,368.67
-1,051.82
-2,080.52
-12,624.07
Cash Flow from Financing Activities
-530.74
-7.81
604.62
-739.72
5.27
10,232.56
Net Cash Flow
103.42
-92.4
155.73
21.76
77.19
21.87

Mankind Pharma Stock Shareholding Pattern

Numbers in percentages

Mar 2023
May 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Promoters
76.5%
76.5%
76.5%
76.5%
76.5%
74.88%
74.87%
74.87%
72.71%
72.7%
72.68%
72.67%
72.66%
DII
2.64%
2.64%
4.64%
4.39%
9.49%
11.14%
9.95%
9.9%
11.06%
11.48%
11.5%
11.92%
13.25%
FII
0%
0%
0%
0%
0%
9.87%
11.58%
12.37%
13.34%
12.92%
13.07%
12.84%
11.34%
Public
18.25%
18.25%
14.68%
14.76%
6.97%
4.11%
3.61%
2.86%
2.9%
2.9%
2.75%
2.57%
2.75%
Total Outstanding Shares
40,05,88,440
40,05,88,440
40,05,88,440
40,05,88,440
40,05,88,440
40,05,88,440
40,06,35,138
40,06,44,138
41,25,66,899
41,25,78,527
41,27,28,748
41,27,58,490
41,28,05,072
Total Shareholders
4,02,322
4,02,322
1,31,918
1,34,731
1,27,449
1,35,116
1,53,450
1,63,854
1,71,281
1,80,597
1,79,549
1,70,347
1,77,539

Mutual Funds that own Mankind Pharma Stock

Check out the Mutual Funds with significant holdings in Mankind Pharma.

Mankind Pharma Corporate Actions

View detailed summary of the earnings and dividend history of Mankind Pharma.

  • Mankind Pharma Ltd Earnings Results

    Mankind Pharma Ltd’s net profit jumped 7.5% since last year same period to ₹408.75Cr in the Q3 2025-2026. On a quarterly growth basis, Mankind Pharma Ltd has generated -20.09% fall in its net profits since last 3-months.

    Read More about Earnings Results

  • Mankind Pharma Ltd Dividends July,2025

    In the quarter ending June 2025, Mankind Pharma Ltd has declared dividend of ₹1.00 per share on 31 Jul 2025 - translating a dividend yield of 0.05%.

    Read More about Dividends

Indices Featuring Mankind Pharma Stock

Check stock indices that include Mankind Pharma.

NIFTY PHARMA

₹22,194.90

-0.85 (▲191.40%)

Nifty Midcap 100

₹59,438.00

-1.71 (▲1032.85%)

Nifty Midcap Sel

₹13,628.35

-1.91 (▲265.15%)

Nifty 200

₹14,221.90

-1.41 (▲203.60%)

Nifty MidSmallcap 400

₹19,694.05

-1.64 (▲328.30%)

BSE Healthcare

₹42,636.95

-1.05 (▲450.77%)

Nifty Midcap 50

₹16,960.45

-1.69 (▲291.05%)

Nifty 500

₹23,313.15

-1.43 (▲338.40%)

Nifty LargeMidcap 250

₹16,518.00

-1.50 (▲251.60%)

BSE 200

₹11,555.65

-1.36 (▲158.79%)

Nifty Healthcare

₹14,384.05

-0.85 (▲123.00%)

S&P BSE 100 LargeCap TMC

₹9,428.16

-1.33 (▲127.24%)

Nifty Midcap 150

₹21,884.35

-1.65 (▲368.05%)

S&P BSE 250 LargeMidCap

₹10,944.82

-1.38 (▲153.68%)

BSE 500

₹36,532.48

-1.40 (▲516.92%)

Insights on Mankind Pharma Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 2.57% to 2.75% in Dec 2025 quarter

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 7.78% to 9.30% in Dec 2025 quarter

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 12.84% to 11.34% in Dec 2025 quarter

  • imgNEGATIVE IMPACT

    Promoter Holding Down

    img

    Promoters have decreased holdings from 72.67% to 72.66% in Dec 2025 quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 3.79K Cr → 3.64K Cr (in ₹), with an average decrease of 3.9% per quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 511.51 Cr → 408.75 Cr (in ₹), with an average decrease of 20.1% per quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, MANKIND stock has moved down by -5.3%

Mankind Pharma Stock Futures & Options Contracts

View the latest movement in Mankind Pharma Futures & Options, including strike prices, expiry dates, and percentage changes.

Mankind Pharma Options

Name
Expiry
Strike Price
LTP
Absolute Change
Change
MANKIND 24 Feb ₹2100 Call
February 24, 2026
₹2100
₹22
-10.5
-32.31%
MANKIND 24 Feb ₹2160 Call
February 24, 2026
₹2160
₹9.5
-4.9
-34.03%
MANKIND 24 Feb ₹2080 Call
February 24, 2026
₹2080
₹30
-12.75
-29.82%
MANKIND 24 Feb ₹2180 Call
February 24, 2026
₹2180
₹6.8
-3.65
-34.93%

Mankind Pharma Futures

Name
Expiry
Strike Price
LTP
Absolute Change
Change
MANKIND 24 Feb Fut
February 24, 2026
-
₹2055.7
-28.34
-1.36%
MANKIND 30 Mar Fut
March 30, 2026
-
₹2059.6
-23.12
-1.11%
MANKIND 28 Apr Fut
April 28, 2026
-
₹2076.6
-14.43
-0.69%

About Mankind Pharma Ltd

Mankind Pharma Ltd. was established in 1991 as a Private Limited Company. In 2005 it was converted to a Public Limited Company and the name changed to Mankind Pharma Limited. The Company is engaged in the development, manufacturing and marketing of a range of pharmaceuticals and consumer healthcare products, and is active in acute and chronic therapeutic areas such as anti-infectives, cardiovascular and gastrointestinal treatments, antidiabetic and neuro/CNS medicines, vitamins, minerals and nutrients. In 2004, they entered the chronic pharmaceutical segment, and have added further products over the years, including ophthalmic products, consumer healthcare products, animal healthcare products and specialty therapeutic divisions. They operate 23 manufacturing facilities across India and had 2181 manufacturing personnel as of March 31, 2021. It is now planning to raise capital through the public offering of 40058844 equity shares, with a total installed capacity of 40.77 billion units across a range of products.

Revenue: ₹3,567.20Cr as on December 2025 (Q3 FY26)
Net Profit: ₹413.88Cr as on December 2025 (Q3 FY26)
Listing date: 09 May, 2023
Chairperson Name: RAMESH CHAND JUNEJA
OrganisationMankind Pharma Ltd
HeadquartersNew Delhi
IndustryPharmaceuticals
CEORAMESH CHAND JUNEJA
E-voting on sharesClick here to vote

FAQs

What is Mankind Pharma share price today?

Mankind Pharma share price today stands at ₹2060.5 as on at the close of the market. Mankind Pharma share today touched a day high of ₹2085.3 and a low of ₹2050.1.

What is the 52 week high and 52 week low range for Mankind Pharma share?

Mankind Pharma touched a 52 week high of ₹2716.5 and a 52 week low of ₹2033. Mankind Pharma share price today i.e. is closed at ₹2060.5, which is -24.15% down from its 52 week high and 1.35% up from its 52 week low.

What is Mankind Pharma's market capitalisation today?

Mankind Pharma market capitalisation is ₹85,058.49 Cr as on .

How to buy Mankind Pharma shares?

To buy Mankind Pharma shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for MANKIND or Mankind Pharma Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Mankind Pharma shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Mankind Pharma trading volume today?

Mankind Pharma trading volume is 2.08L as on . This means that 2.08L shares of Mankind Pharma were bought and sold on the stock market during today's trading session.